Appeal 2007-2656 Application 11/133,685 such as trialkylaluminum, for combination with the catalyst component prepared from a magnesium dialkoxide that was contacted with a halogenation agent followed with three successive titanating contacting steps (Shamshoum col. 5, ll. 28-39). Here, representative claim 5 is not so limited as to exclude the described organometallic co-catalyst of Shamshoum by use of the claim phrase “preactivating agent.” See In re Self, 671 F.2d 1344, 1350-1351, 213 USPQ 1, 7 (CCPA 1982). Indeed, Appellants disclose that the claimed preactivation agent is inclusive of an organometallic compound (Specification ¶¶ 0044 and 0045) and the same trialkyl aluminum as the organometallic preactivating agent is specified in claim 3. It follows that this argument is not persuasive of any reversible error in the stated rejection. Having reconsidered the Examiner’s anticipation rejection in light of Appellants’ arguments as presented in the Briefs, we remain persuaded that the representative claim 5 catalyst is anticipated by the catalyst described in Shamshoum. ORDER The decision of the Examiner to reject claims 2-7 under 35 U.S.C. § 102(b) as being anticipated by Shamshoum is affirmed. 6Page: Previous 1 2 3 4 5 6 7 Next
Last modified: September 9, 2013